SCYNEXIS, Inc. (NASDAQ: SCYX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
SCYNEXIS, Inc. (NASDAQ: SCYX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
SCYNEXIS Reports Full Year 2024 Financial Results and Provides Corporate Update
NanoNewron and its Research to Advance the Treatment of Alzheimer's Disease are Featured by Rutgers University Newsletters and on Rutgers Today [Yahoo! Finance]
Candidiasis Global Clinical Trials Review 2024: Top Countries, Trial Status, Trial Phase, Sponsor Type and End Point Status [Yahoo! Finance]